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Background
Cardiac autonomic neuropathy (CAN) is frequently
underdiagnosed. The prevalence of CAN rises with dia-
betes duration and poor glycemic control. Individuals
with DM and CAN have an increased mortality risk, up
to 53% five yrs. after diagnosis. Early identification can
improve treatment, quality of life and mortality.
Objective
Our aim was to determine the prevalence of CAN in
patients with type 1 diabetes (T1D) and its association
with clinical characteristics.
Materials and methods
We evaluated 102 patients with T1D (67% female)
divided in 2 groups: with and without CAN. Mean age
and HcA1c were 34,27±10,96 yrs. and 9.0±2.0%, respec-
tively. CAN was assessed by Poly-Spectrum software
using standardized cardiovascular reflex testing and
measures of heart rate variability. Statistical significance
was set at 5%.
Results
CAN was diagnosed in 39 (38.2%) patients. No statistically
significant differences were found in age (34.87±9.71 vs.
33.90±11.74 yrs.; p=0.467), age at diagnosis (15.10±9.16 vs.
17.38±11.29 yrs.; p=0.495) and HbA1c (9.26%±2.04 vs.
8.84%±2.07; p=0.144) between groups. Hypertension and
dyslipidemia were seen more frequently in patients with
CAN (61.5 vs. 19%; p≤0.001 and 51.3 vs. 22.2%; p=0.002,
respectively). Patients with CAN had higher total choles-
terol (p=0.009) and triglycerides (p=0.004). Patients with
CAN complained more often of post-prandial sweating
and orthostatic hypotension (35.9 vs. 14.3%; p=0.011 and
51.3 vs. 30.2%; p=0.033, respectively). Other symptoms
questioned were similar between groups, including
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Figure 1 Clinical predictors of cardiac autonomic neuropathy in
patients with type 1 diabetes. Values are shown as frequency (%)
and mean (standard deviation).
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hypoglycemia (p=0.7). CAN showed a rising prevalence as
complication severity increased. For retinopathy, the fre-
quency of CAN was 54.2%, 60%, 75% and 80% in those
with nonproliferative, proliferative, unilateral and bilateral
blindness, respectively (p<0.001). Regarding nephropathy,
CAN was present in 41.2%, 75%, 88.9%, 100% and 100% in
patients with microalbuminuria, macroalbuminuria,
chronic kidney disease, hemodialysis and kidney trans-
plant, respectively (p=<0.001). Diabetic neuropathy, motor
sensory neuropathy/symmetric polyneuropathy and more
than one neuropathy were seen in 72% and 100% of
patients with CAN, respectively (p=0.001).
Conclusions
These results support an association of increased CAN
prevalence and chronic complications and their severity.
CAN was also associated with hypertension and dyslipi-
demia, but with few autonomic symptoms (post-prandial
sweating and orthostatic hypotension). As expected,
HbA1c had no relevance in CAN occurrence.
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